Form 4: Eli Lilly Director Defers Compensation into Stock Units

Eli Lilly Director Ralph Alvarez acquired 11.924 shares of common stock by deferring cash compensation into stock units under the company's deferral plan.

Summary

• Ralph Alvarez, a Director at Eli Lilly & Co (LLY), acquired 11.924 shares of common stock.
• The transaction occurred on January 20, 2026.
• These shares were acquired by deferring cash compensation as stock units under the Lilly Directors' Deferral Plan.
• The total value of the acquired shares was $1,041.29.
• The stock units will be settled in shares of common stock following Alvarez's separation from service.
• Following this transaction, Alvarez directly beneficially owns 55,479.642 shares and indirectly owns 758 shares through a trust.

Sentiment

Score: 7

Explanation: The acquisition of shares by a director, even through deferred compensation, generally indicates confidence in the company's future performance and aligns the director's interests with those of shareholders.

Positives

• Director Ralph Alvarez increased his beneficial ownership in Eli Lilly & Co by acquiring 11.924 shares.
• The acquisition demonstrates a director's commitment and alignment with shareholder interests by choosing to defer cash compensation into company stock.

Negatives

• No negative aspects are reported in this Form 4 filing.

Risks

• No specific risks are mentioned in this Form 4 filing.

Future Outlook

The acquired stock units will be settled in shares of common stock following Ralph Alvarez's separation from service, indicating a future conversion event.

Management Comments

• No direct quotes from management are provided in this Form 4 filing. The transaction itself reflects a decision by the reporting person.

Industry Context

This Form 4 filing details a routine insider transaction where a director defers compensation into company stock, a common practice in corporate governance to align executive interests with shareholders. It does not provide broader industry trends.

Comparison to Industry Standards

• This filing reports a standard practice of director compensation deferral into equity, which is common across publicly traded companies to foster long-term alignment between directors and shareholders. No specific comparable companies or projects are mentioned in the filing.

Corporate Governance

Related Party Transactions

• The acquisition of common stock by a director (Ralph Alvarez) from the issuer (Eli Lilly & Co) constitutes a related party transaction, specifically an insider transaction.

Stakeholder Impact

• Shareholders: Potentially positive, as a director increasing their stake (even deferred) can signal confidence in the company's future, aligning director interests with shareholder value.

Next Steps

• Settlement of the acquired stock units into common stock shares upon Ralph Alvarez's separation from service.

Key Dates

Keywords

Eli Lilly, LLY, Ralph Alvarez, Director, Insider Transaction, Form 4, Stock Units, Deferred Compensation, Common Stock, Beneficial Ownership